OliX Pharmaceuticals Statistics

Total Valuation

KOSDAQ:226950 has a market cap or net worth of KRW 764.68 billion. The enterprise value is 792.08 billion.

Market Cap	764.68B
Enterprise Value	792.08B

Important Dates

The last earnings date was Wednesday, March 19, 2025.

Earnings Date	Mar 19, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:226950 has 18.63 million shares outstanding. The number of shares has increased by 16.74% in one year.

Current Share Class	n/a
Shares Outstanding	18.63M
Shares Change (YoY)	+16.74%
Shares Change (QoQ)	+3.14%
Owned by Insiders (%)	19.49%
Owned by Institutions (%)	17.38%
Float	15.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	121.79
PB Ratio	42.45
P/TBV Ratio	47.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.48
EV / Sales	139.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.08

Financial Position

The company has a current ratio of 0.52, with a Debt / Equity ratio of 2.12.

Current Ratio	0.52
Quick Ratio	0.44
Debt / Equity	2.12
Debt / EBITDA	n/a
Debt / FCF	-0.94
Interest Coverage	-6.63

Financial Efficiency

Return on equity (ROE) is -118.18% and return on invested capital (ROIC) is -26.23%.

Return on Equity (ROE)	-118.18%
Return on Assets (ROA)	-22.20%
Return on Invested Capital (ROIC)	-26.23%
Return on Capital Employed (ROCE)	-75.07%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.07
Inventory Turnover	0.49

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +130.03% in the last 52 weeks. The beta is 0.57, so KOSDAQ:226950's price volatility has been lower than the market average.

Beta (5Y)	0.57
52-Week Price Change	+130.03%
50-Day Moving Average	36,749.00
200-Day Moving Average	22,264.10
Relative Strength Index (RSI)	43.01
Average Volume (20 Days)	1,252,760

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:226950 had revenue of KRW 5.68 billion and -40.66 billion in losses. Loss per share was -2,414.00.

Revenue	5.68B
Gross Profit	5.43B
Operating Income	-30.92B
Pretax Income	-41.07B
Net Income	-40.66B
EBITDA	-28.29B
EBIT	-30.92B
Loss Per Share	-2,414.00

Full Income Statement

Balance Sheet

The company has 12.41 billion in cash and 39.19 billion in debt, giving a net cash position of -26.78 billion or -1,437.51 per share.

Cash & Cash Equivalents	12.41B
Total Debt	39.19B
Net Cash	-26.78B
Net Cash Per Share	-1,437.51
Equity (Book Value)	18.47B
Book Value Per Share	966.92
Working Capital	-14.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.04 billion and capital expenditures -13.46 billion, giving a free cash flow of -41.51 billion.

Operating Cash Flow	-28.04B
Capital Expenditures	-13.46B
Free Cash Flow	-41.51B
FCF Per Share	-2,228.35

Full Cash Flow Statement

Margins

Gross Margin	95.62%
Operating Margin	-544.61%
Pretax Margin	-723.44%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:226950 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-16.74%
Shareholder Yield	-16.74%
Earnings Yield	-5.32%
FCF Yield	-5.43%

Stock Splits

The last stock split was on December 3, 2020. It was a forward split with a ratio of 2.

Last Split Date	Dec 3, 2020
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:226950 has an Altman Z-Score of -1.73. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.73
Piotroski F-Score	n/a